{"database": "lobbying", "table": "lobbying_activities", "rows": [[2338101, "cfb8697f-6e73-4a24-88ef-a0307bb5c136", "Q3", "CAMERON COMPANIES", 401095057, "FOX CHASE CANCER CENTER", 2019, "third_quarter", "MMM", "Monitored the introduction of drug pricing legislation for its potential impact on existing and emerging cancer drug therapies and site neutrality.  Monitored Medicare reimbursement developments in the agencies and Congress for alternative cancer therapies such as CAR-T.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2019-10-03T09:06:06.240000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2338101"], "units": {}, "query_ms": 76.94183301646262, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}